Milestone Scientific Inc. (NYSE: MLSS) investors back higher share and equity plan limits
Rhea-AI Filing Summary
Milestone Scientific Inc. reported outcomes of its 2026 annual stockholders meeting and related board actions. Stockholders elected five incumbent directors to serve until the 2027 annual meeting, approved increasing authorized common shares from 125,000,000 to 135,000,000, expanded the Amended and Restated 2020 Equity Incentive Plan from 11,500,000 to 28,750,000 shares, approved on an advisory basis compensation of named executive officers, and ratified Grassi & Co. Certified Public Accountants, PC as independent auditors. At the record date there were 88,449,412 common shares outstanding, and 44,335,594 shares, or 50.12%, were represented, constituting a quorum.
The board re-elected Kelly Ulto and Greg Shilling as directors effective July 27, 2026, to serve until the 2027 annual meeting, reaffirmed that both are independent, determined that Ulto qualifies as an audit committee financial expert, and appointed Ulto and Shilling as chairs and members of various board committees.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 5.02, 5.07
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Authorized common shares after amendment: 135,000,000
Prior authorized common shares: 125,000,000
Equity plan share limit after increase: 28,750,000
+5 more
8 metrics
Authorized common shares after amendment
135,000,000
Authorized shares of common stock following stockholder approval at the 2026 annual meeting
Prior authorized common shares
125,000,000
Authorized shares of common stock before amendment to Restated Certificate of Incorporation
Equity plan share limit after increase
28,750,000
Shares available for issuance under Amended and Restated 2020 Equity Incentive Plan after stockholder approval
Prior equity plan share limit
11,500,000
Shares previously available under the 2020 Equity Incentive Plan before amendment
Shares outstanding at record date
88,449,412
Common shares outstanding at the record date for the 2026 annual meeting
Shares represented at meeting
44,335,594
Common shares represented in person or by proxy at the 2026 annual meeting
Meeting participation
50.12%
Percentage of issued and outstanding common stock represented at the 2026 annual meeting
Say-on-pay approval rate
83.55%
Percentage of votes cast for advisory approval of named executive officer compensation
Key Terms
audit committee financial expert, Restated Certificate of Incorporation, Amended and Restated 2020 Equity Incentive Plan, broker non-votes
4 terms
audit committee financial expert regulatory
"Reaffirmed its determination that Ms. Ulto qualifies as an audit committee financial expert"
A person on a company’s board who has deep knowledge of accounting, financial reporting and auditing, able to understand and question the books, controls and audit work like a trained mechanic inspecting an engine. Investors care because that expertise helps spot errors, weaknesses or misleading statements early, improving the likelihood that financial reports are accurate and reducing the risk of surprises that can hurt a company’s value.
Restated Certificate of Incorporation regulatory
"Approved an amendment to the Company’s Restated Certificate of Incorporation increasing the number of authorized shares"
A restated certificate of incorporation is an updated, single-document version of a company’s founding rules that folds together the original charter and all later changes into one clear set of terms — like replacing a patchwork manual with a clean, revised edition. Investors care because it clarifies ownership details, voting rights, share classes and other legal rules that affect control, dividends and how value is created or diluted, so it can change the risks and benefits of owning the stock.
Amended and Restated 2020 Equity Incentive Plan financial
"Approved an amendment to the Company’s Amended and Restated 2020 Equity Incentive Plan to increase the number of shares"
broker non-votes regulatory
"The number of abstentions and broker non-votes with respect to each proposal is set forth below"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What key items did Milestone Scientific (MLSS) stockholders approve at the 2026 annual meeting?
Milestone Scientific (MLSS) stockholders approved director elections, higher authorized share and equity plan limits, executive pay and auditor ratification. They elected five incumbent directors, raised authorized common shares to 135,000,000, expanded the 2020 Equity Incentive Plan to 28,750,000 shares, and confirmed Grassi & Co. as auditors.
What change was approved to Milestone Scientific (MLSS) 2020 Equity Incentive Plan?
Milestone Scientific (MLSS) stockholders approved increasing shares available under the Amended and Restated 2020 Equity Incentive Plan from 11,500,000 to 28,750,000. The proposal received 18,716,361 votes for and 4,440,070 against, with 189,660 abstentions, representing 80.82% of votes cast in favor.
What was the quorum and participation level for the Milestone Scientific (MLSS) 2026 annual meeting?
For Milestone Scientific (MLSS), 88,449,412 common shares were outstanding at the record date, and 44,335,594 shares were represented. This represented 50.12% of issued and outstanding common stock, satisfying quorum requirements for the 2026 annual meeting of stockholders.
What board and committee roles were given to Kelly Ulto and Greg Shilling at Milestone Scientific (MLSS)?
Milestone Scientific (MLSS) re-elected Kelly Ulto and Greg Shilling as directors effective July 27, 2026. Ulto was named Audit Committee Chair and joined the Compensation and Nominating and Corporate Governance Committees, while Shilling became Compensation Committee Chair and joined the Audit and Nominating and Corporate Governance Committees.
How did Milestone Scientific (MLSS) stockholders vote on executive compensation and auditors?
Milestone Scientific (MLSS) stockholders approved, on an advisory basis, compensation of named executive officers with 83.55% of votes cast in favor. They also ratified Grassi & Co. Certified Public Accountants, PC as independent auditors, with 41,403,142 votes for and 979,118 against.